600,000 Bottles of Blood Pressure Drug Ramipril Recalled Over Contamination Risk
Approximately 600,000 bottles of Ramipril, a widely used blood pressure medication, are being recalled in the U.S. due to concerns over contamination linked to an unregulated supplier in India, according to an announcement by the FDA. The recall affects 2.5 mg, 5 mg, and 10 mg doses distributed nationwide.
The FDA has classified this as a Class 2 recall, which means the product may cause temporary or medically reversible health issues, though the risk of serious adverse consequences is remote. Importantly, no health incidents have been reported so far, but patients are urged to review their prescriptions and consult with their healthcare providers if they suspect their medication is part of the affected batch.
